Tapewire

NYSE · USD

ACR

ACRES Commercial Realty Corp.

Export transactions ↓
Tapewire entity
6763
SEC CIK
0001332551
Parsed reports
358

Last 12 months

Inside the activity.

0 purchase rows · 71 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025012
Dec 2025011
Jan 202609
Feb 2026010
Mar 202605
Apr 202600
May 202601
Jun 2026010
Jul 2026011
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2020 Filed Mar 13, 2020 20:10 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 2,100 $23.90 $50,188.74
Disclosure

SEC source: 0001567619-20-006298 · doc1.xml · nonDerivative · entry 2

Lieber Robert C · CIK 0001616149 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

Read SEC document
March 11, 2020 Filed Mar 13, 2020 20:10 UTC PurchaseCommon Stock 5,100 $9.80 $49,962.15
Disclosure

SEC source: 0001567619-20-006298 · doc1.xml · nonDerivative · entry 1

Lieber Robert C · CIK 0001616149 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,083

F1 · balance_after: Includes 23,083 shares which remain subject to vesting under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan.

Read SEC document
March 10, 2020 Filed Mar 11, 2020 16:30 UTC PurchaseCommon Stock 48,355 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-20-006090 · doc1.xml · nonDerivative · entry 3

FARKAS ANDREW L · CIK 0001026285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,627

F4 · price: On March 10, 2020, the reporting person purchased, in multiple transactions, a total of 48,355 shares of common stock of the Issuer at prices ranging from $10.005 to $10.46.

F5 · balance_after: Includes 27,700 shares which remain subject to vesting under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan.

Read SEC document
March 10, 2020 Filed Mar 11, 2020 16:30 UTC PurchaseCommon Stock 38,600 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-20-006090 · doc1.xml · nonDerivative · entry 2

FARKAS ANDREW L · CIK 0001026285 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Limited Liability Company

Disclosed balance after: 38,600

F3 · price: On March 10, 2020, the reporting person purchased through a limited liability company, in multiple transactions, a total of 38,600 shares of common stock of the Issuer at prices ranging from $10.07 to $10.415.

F2 · ownership.nature: The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purposes.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 16:07 UTC PurchaseCommon Stock 1,549 $10.25 $15,877.25
Disclosure

SEC source: 0001567619-20-006176 · doc1.xml · nonDerivative · entry 1

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,237

F1 · balance_after: Includes 23,083 shares which remain subject to vesting under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:08 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 999 $24.80 $24,775.20
Disclosure

SEC source: 0001567619-20-006000 · doc1.xml · nonDerivative · entry 3

Stern Matthew J · CIK 0001684588 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:08 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 1 $24.63 $24.63
Disclosure

SEC source: 0001567619-20-006000 · doc1.xml · nonDerivative · entry 2

Stern Matthew J · CIK 0001684588 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,001

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:08 UTC PurchaseCommon Stock 5,000 $10.17 $50,850.00
Disclosure

SEC source: 0001567619-20-006000 · doc1.xml · nonDerivative · entry 1

Stern Matthew J · CIK 0001684588 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,485

F1 · balance_after: Includes 25,194 shares which remain subject to vesting under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:15 UTC GrantCommon Stock 3,451 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-006011 · doc1.xml · nonDerivative · entry 1

LEVIN MURRAY S · CIK 0001237925 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,003

F1 · price: The reporting person has been granted 3,451 shares of restricted common stock under the Issuer's Second Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 9, 2021 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 20:11 UTC GrantCommon Stock 3,944 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-006006 · doc1.xml · nonDerivative · entry 1

NEFF P SHERRILL · CIK 0001189158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,783

F1 · price: The reporting person has been granted 3,944 shares of restricted common stock under the Issuer's Second Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 9, 2021 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:10 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 5,330 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-20-006003 · doc1.xml · nonDerivative · entry 5

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse IRA

Disclosed balance after: 6,830

F2 · price: On March 9, 2020, the reporting person's spouse purchased in her IRA, in multiple transactions, a total of 5,330 shares of 8.625% Series C Cumulative Redeemable Preferred Stock of the Issuer at prices ranging from $24.75 to $24.80.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 16:26 UTC GrantCommon Stock 3,451 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-006019 · doc1.xml · nonDerivative · entry 1

HART WILLIAM B · CIK 0001192079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,878

F1 · price: The reporting person has been granted 3,451 shares of restricted common stock under the Issuer's Second Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 9, 2021 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 16:30 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 3,607 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-20-006090 · doc1.xml · nonDerivative · entry 1

FARKAS ANDREW L · CIK 0001026285 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Limited Liability Company

Disclosed balance after: 3,607

F1 · price: On March 9, 2020, the reporting person purchased through a limited liability company, in multiple transactions, a total of 3,607 shares of 8.625% Series C Cumulative Redeemable Preferred Stock of the Issuer at prices ranging from $24.790 to $25.00.

F2 · ownership.nature: The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purposes.

Read SEC document
March 06, 2020 Filed Mar 10, 2020 16:10 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 500 $25.60 $12,800.00
Disclosure

SEC source: 0001567619-20-006003 · doc1.xml · nonDerivative · entry 4

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse IRA

Disclosed balance after: 1,500

Read SEC document
March 06, 2020 Filed Mar 10, 2020 16:10 UTC Purchase8.625% Series C Cumulative Redeemable Preferred Stock 1,000 $25.60 $25,600.00
Disclosure

SEC source: 0001567619-20-006003 · doc1.xml · nonDerivative · entry 3

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
March 06, 2020 Filed Mar 10, 2020 16:10 UTC PurchaseCommon Stock 10,000 $10.75 $107,500.00
Disclosure

SEC source: 0001567619-20-006003 · doc1.xml · nonDerivative · entry 1

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,688

F1 · balance_after: Includes 23,083 shares which remain subject to vesting under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:07 UTC GrantCommon Stock 2,843 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-002789 · doc4.xml · nonDerivative · entry 1

Ickowicz Gary · CIK 0001387822 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,322

F1 · price: The reporting person has been granted 2,843 shares of restricted common stock. These shares will fully vest on February 3, 2021 and are receivable on account of the undersigned's service as a director of the Company and without additional consideration.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 16:05 UTC GrantCommon Stock 12,668 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001817 · doc4.xml · nonDerivative · entry 1

FARKAS ANDREW L · CIK 0001026285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,272

F1 · price: The Reporting Person has been granted 12,668 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 37,716 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 16:11 UTC GrantCommon Stock 6,334 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001823 · doc4.xml · nonDerivative · entry 1

Hughson Paul A · CIK 0001684524 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,532

F1 · price: The Reporting Person has been granted 6,334 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 17,857 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 16:05 UTC GrantCommon Stock 12,668 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001816 · doc4.xml · nonDerivative · entry 1

Stern Matthew J · CIK 0001684588 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,485

F1 · price: The Reporting Person has been granted 12,668 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 29,201 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:15 UTC
BRYANT DAVID JSVP, CFO & Tresurer
GrantCommon Stock 8,445 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001827 · doc4.xml · nonDerivative · entry 1

BRYANT DAVID J · CIK 0001203103 · SVP, CFO & Tresurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,356

F1 · price: The Reporting Person has been granted 8,445 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 22,473 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 16:07 UTC GrantCommon Stock 10,557 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001820 · doc4.xml · nonDerivative · entry 1

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,188

F1 · price: The Reporting Person has been granted 10,557 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 29,093 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:12 UTC GrantCommon Stock 2,956 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001825 · doc4.xml · nonDerivative · entry 1

Blackwell Eldron C · CIK 0001603881 · VP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,298

F1 · price: The Reporting Person has been granted 2,956 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 7,165 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:06 UTC GrantCommon Stock 10,557 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001818 · doc4.xml · nonDerivative · entry 1

Lieber Robert C · CIK 0001616149 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,983

F1 · price: The Reporting Person has been granted 10,557 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 29,093 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:07 UTC GrantCommon Stock 8,445 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001819 · doc4.xml · nonDerivative · entry 1

Elliott Thomas C · CIK 0001332163 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,279

F1 · price: The Reporting Person has been granted 8,445 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 24,476 shares remain subject to vesting.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:08 UTC
Weisbaum Michele R.SVP, CLO & Secretary
GrantCommon Stock 6,334 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-001821 · doc4.xml · nonDerivative · entry 1

Weisbaum Michele R. · CIK 0001518012 · SVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,473

F1 · price: The Reporting Person has been granted 6,334 shares of restricted stock under the Issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 21, 2021.

F2 · balance_after: 14,185 shares remain subject to vesting.

Read SEC document
September 30, 2019 Filed Oct 2, 2019 20:16 UTC GrantCommon Stock 3,078 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-019062 · doc1.xml · nonDerivative · entry 1

KESSLER STEVEN J · CIK 0001230072 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,281

F1 · price: The reporting person was granted 3,078 restricted common shares under the issuer's Second Amended and Restated Omnibus Equity Compensation Plan. These shares will fully vest on September 30, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
July 19, 2019 Filed Jul 23, 2019 21:25 UTC Disposition to issuerCommon Stock 3,170 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-015108 · doc1.xml · nonDerivative · entry 1

Wiggins Stephanie H. · CIK 0001578798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890

F1 · price: The reporting person's unvested shares of restricted stock under the issuer's equity compensation plan were forfeited in connection with her resignation.

Read SEC document
June 19, 2019 Filed Jun 20, 2019 20:14 UTC GrantCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-013759 · doc1.xml · nonDerivative · entry 1

Ickowicz Gary · CIK 0001387822 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,479

F1 · price: The reporting person has been granted 900 shares of restricted common stock. These shares will fully vest on June 19, 2020.

Read SEC document
June 06, 2019 Filed Jun 7, 2019 20:18 UTC GrantCommon Stock 3,170 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-013059 · doc1.xml · nonDerivative · entry 1

Wiggins Stephanie H. · CIK 0001578798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,060

F1 · price: The reporting person has been granted 3,170 shares of restricted common stock under the issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will fully vest on June 6, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 16:19 UTC GrantCommon Stock 3,164 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-012825 · doc1.xml · nonDerivative · entry 1

SILVERMAN HENRY R · CIK 0001079609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,232

F1 · price: The reporting person has been granted 3,164 shares of restricted common stock under the issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will fully vest on June 3, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 17:39 UTC GrantCommon Stock 3,292 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006587 · doc1.xml · nonDerivative · entry 1

LEVIN MURRAY S · CIK 0001237925 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,552

F1 · price: The reporting person has been granted 3,292 shares of restricted common stock under the issuer's Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 8, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 17:49 UTC Amendment GrantCommon Stock 3,292 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006592 · doc1.xml · nonDerivative · entry 1

HART WILLIAM B · CIK 0001192079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,427

F1 · price: The reporting person has been granted 3,292 shares of restricted common stock under the Issuer's Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 8, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 17:28 UTC GrantCommon Stock 3,292 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006585 · doc1.xml · nonDerivative · entry 1

HART WILLIAM B · CIK 0001192079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,623

F1 · price: The reporting person has been granted 3,292 shares of restricted common stock under the Issuer's Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 8, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 17:25 UTC GrantCommon Stock 3,762 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006582 · doc1.xml · nonDerivative · entry 1

Beach Walter T · CIK 0001312739 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,473

F1 · price: The reporting person has been granted 3,762 shares of restricted common stock under the issuer's Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 8, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
March 08, 2019 Filed Mar 12, 2019 20:26 UTC GrantCommon Stock 3,762 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006677 · doc1.xml · nonDerivative · entry 1

NEFF P SHERRILL · CIK 0001189158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,839

F1 · price: The reporting person has been granted 3,762 shares of restricted common stock under the issuer's Amended & Restated Omnibus Equity Compensation Plan. These shares will fully vest on March 8, 2020 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
February 01, 2019 Filed Feb 4, 2019 22:01 UTC GrantCommon Stock 3,308 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-002273 · doc1.xml · nonDerivative · entry 1

Ickowicz Gary · CIK 0001387822 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,579

F1 · price: The reporting person has been granted 3,308 shares of restricted common stock. These shares will fully vest on February 1, 2020 and are receivable on account of the undersigned's service as a director of the Company and without additional consideration.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 16:52 UTC GrantCommon Stock 14,734 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001881 · doc4.xml · nonDerivative · entry 1

FARKAS ANDREW L · CIK 0001026285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,604

F1 · price: The Reporting Person has been granted 14,734 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 45,183 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 16:56 UTC GrantCommon Stock 7,367 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001896 · doc4.xml · nonDerivative · entry 1

Hughson Paul A · CIK 0001684524 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,198

F1 · price: The Reporting Person has been granted 7,367 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 20,588 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 16:53 UTC GrantCommon Stock 12,278 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001891 · doc4.xml · nonDerivative · entry 1

Stern Matthew J · CIK 0001684588 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,817

F1 · price: The Reporting Person has been granted 12,278 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 28,971 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 16:53 UTC GrantCommon Stock 12,278 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001892 · doc4.xml · nonDerivative · entry 1

COHEN JEFFREY P · CIK 0001191803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,631

F1 · price: The Reporting Person has been granted 12,278 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 32,977 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:55 UTC
BRYANT DAVID JSVP, CFO & Tresurer
GrantCommon Stock 9,823 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001894 · doc4.xml · nonDerivative · entry 1

BRYANT DAVID J · CIK 0001203103 · SVP, CFO & Tresurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,911

F1 · price: The Reporting Person has been granted 9,823 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 24,780 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:53 UTC GrantCommon Stock 9,823 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001886 · doc4.xml · nonDerivative · entry 1

Elliott Thomas C · CIK 0001332163 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,834

F1 · price: The Reporting Person has been granted 9,823 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 33,683 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:53 UTC GrantCommon Stock 12,278 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001890 · doc4.xml · nonDerivative · entry 1

Lieber Robert C · CIK 0001616149 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,426

F1 · price: The Reporting Person has been granted 12,278 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 32,977 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:56 UTC GrantCommon Stock 2,946 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001895 · doc4.xml · nonDerivative · entry 1

Blackwell Eldron C · CIK 0001603881 · VP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,342

F1 · price: The Reporting Person has been granted 2,946 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 7,434 shares remain subject to vesting.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:51 UTC
Weisbaum Michele R.SVP, CLO & Secretary
GrantCommon Stock 7,367 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-001879 · doc4.xml · nonDerivative · entry 1

Weisbaum Michele R. · CIK 0001518012 · SVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,139

F1 · price: The Reporting Person has been granted 7,367 shares of restricted stock under the Issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will vest in full over three years, with 33.33% vesting per year beginning on January 22, 2020.

F2 · balance_after: 13,243 shares remain subject to vesting.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:35 UTC GrantCommon Stock 3,202 $0.00 $0.00
Disclosure

SEC source: 0001567619-18-003651 · doc1.xml · nonDerivative · entry 1

KESSLER STEVEN J · CIK 0001230072 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,203

F1 · price: The reporting person was granted 3,202 restricted common shares under the issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will fully vest on October 1, 2019 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document
August 14, 2018 Filed Aug 15, 2018 20:31 UTC
BRYANT DAVID JSVP, CFO & Treas.
Purchase8.625% Series C Cumulative Redeemable Preferred Stock 2,000 $25.58 $51,150.00
Disclosure

SEC source: 0001567619-18-001185 · doc1.xml · nonDerivative · entry 1

BRYANT DAVID J · CIK 0001203103 · SVP, CFO & Treas.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
June 07, 2018 Filed Jun 8, 2018 20:06 UTC SaleCommon Stock 3,000 $9.96 $29,880.00
Disclosure

SEC source: 0001140361-18-027867 · doc1.xml · nonDerivative · entry 2

Wiggins Stephanie H. · CIK 0001578798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890

Read SEC document
June 06, 2018 Filed Jun 8, 2018 20:06 UTC GrantCommon Stock 3,510 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-027867 · doc1.xml · nonDerivative · entry 1

Wiggins Stephanie H. · CIK 0001578798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,890

F1 · price: The reporting person has been granted 3,510 shares of restricted common stock under the issuer's Amended and Restated Omnibus Equity Compensation Plan. These shares will fully vest on June 6, 2019 and are receivable on account of the reporting person's service as a director of the Company and without additional consideration.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.